Literature DB >> 16826512

The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27.

Ming Der Perng1, Mu Su, Shu Fang Wen, Rong Li, Terry Gibbon, Alan R Prescott, Michael Brenner, Roy A Quinlan.   

Abstract

Here, we describe the early events in the disease pathogenesis of Alexander disease. This is a rare and usually fatal neurodegenerative disorder whose pathological hallmark is the abundance of protein aggregates in astrocytes. These aggregates, termed "Rosenthal fibers," contain the protein chaperones alpha B-crystallin and HSP27 as well as glial fibrillary acidic protein (GFAP), an intermediate filament (IF) protein found almost exclusively in astrocytes. Heterozygous, missense GFAP mutations that usually arise spontaneously during spermatogenesis have recently been found in the majority of patients with Alexander disease. In this study, we show that one of the more frequently observed mutations, R416W, significantly perturbs in vitro filament assembly. The filamentous structures formed resemble assembly intermediates but aggregate more strongly. Consistent with the heterozygosity of the mutation, this effect is dominant over wild-type GFAP in coassembly experiments. Transient transfection studies demonstrate that R416W GFAP induces the formation of GFAP-containing cytoplasmic aggregates in a wide range of different cell types, including astrocytes. The aggregates have several important features in common with Rosenthal fibers, including the association of alpha B-crystallin and HSP27. This association occurs simultaneously with the formation of protein aggregates containing R416W GFAP and is also specific, since HSP70 does not partition with them. Monoclonal antibodies specific for R416W GFAP reveal, for the first time for any IF-based disease, the presence of the mutant protein in the characteristic histopathological feature of the disease, namely Rosenthal fibers. Collectively, these data confirm that the effects of the R416W GFAP are dominant, changing the assembly process in a way that encourages aberrant filament-filament interactions that then lead to protein aggregation and chaperone sequestration as early events in Alexander disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16826512      PMCID: PMC1559481          DOI: 10.1086/504411

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  64 in total

Review 1.  Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics.

Authors:  H Herrmann; U Aebi
Journal:  Curr Opin Cell Biol       Date:  2000-02       Impact factor: 8.382

Review 2.  Functional complexity of intermediate filament cytoskeletons: from structure to assembly to gene ablation.

Authors:  Harald Herrmann; Michael Hesse; Michaela Reichenzeller; Ueli Aebi; Thomas M Magin
Journal:  Int Rev Cytol       Date:  2003

Review 3.  Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular Scaffolds.

Authors:  Harald Herrmann; Ueli Aebi
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

4.  Alexander's disease: a report and reappraisal.

Authors:  L S Russo; A Aron; P J Anderson
Journal:  Neurology       Date:  1976-07       Impact factor: 9.910

Review 5.  Alexander disease: a case report and review of the literature.

Authors:  E A Reichard; W S Ball; K E Bove
Journal:  Pediatr Pathol Lab Med       Date:  1996 Mar-Apr

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Methods to characterize actin filament networks.

Authors:  T D Pollard; J A Cooper
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

8.  HSP27 but not HSP70 has a potent protective effect against alpha-synuclein-induced cell death in mammalian neuronal cells.

Authors:  Alexandra Zourlidou; Martin D Payne Smith; David S Latchman
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

9.  The mechanical properties of simple epithelial keratins 8 and 18: discriminating between interfacial and bulk elasticities.

Authors:  Soichiro Yamada; Denis Wirtz; Pierre A Coulombe
Journal:  J Struct Biol       Date:  2003-07       Impact factor: 2.867

10.  HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation.

Authors:  Arnaud Parcellier; Elise Schmitt; Sandeep Gurbuxani; Daphné Seigneurin-Berny; Alena Pance; Aurélie Chantôme; Stéphanie Plenchette; Saadi Khochbin; Eric Solary; Carmen Garrido
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

View more
  41 in total

1.  Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes.

Authors:  Rujin Tian; Xiaoping Wu; Tracy L Hagemann; Alexandre A Sosunov; Albee Messing; Guy M McKhann; James E Goldman
Journal:  J Neuropathol Exp Neurol       Date:  2010-04       Impact factor: 3.685

2.  Alexander disease causing mutations in the C-terminal domain of GFAP are deleterious both to assembly and network formation with the potential to both activate caspase 3 and decrease cell viability.

Authors:  Yi-Song Chen; Suh-Ciuan Lim; Mei-Hsuan Chen; Roy A Quinlan; Ming-Der Perng
Journal:  Exp Cell Res       Date:  2011-07-02       Impact factor: 3.905

Review 3.  GFAP and its role in Alexander disease.

Authors:  Roy A Quinlan; Michael Brenner; James E Goldman; Albee Messing
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

4.  Protein misfolding and oxidative stress promote glial-mediated neurodegeneration in an Alexander disease model.

Authors:  Liqun Wang; Kenneth J Colodner; Mel B Feany
Journal:  J Neurosci       Date:  2011-02-23       Impact factor: 6.167

5.  Identification of a novel nonsense mutation in the rod domain of GFAP that is associated with Alexander disease.

Authors:  Tai-Seung Nam; Jin Hee Kim; Chi-Hsuan Chang; Woong Yoon; Yoon Seok Jung; Sa-Yoon Kang; Boo Ahn Shin; Ming-Der Perng; Seok-Yong Choi; Myeong-Kyu Kim
Journal:  Eur J Hum Genet       Date:  2014-04-23       Impact factor: 4.246

6.  Electron paramagnetic resonance analysis of the vimentin tail domain reveals points of order in a largely disordered region and conformational adaptation upon filament assembly.

Authors:  John F Hess; Madhu S Budamagunta; Atya Aziz; Paul G FitzGerald; John C Voss
Journal:  Protein Sci       Date:  2013-01       Impact factor: 6.725

7.  Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice.

Authors:  Woosung Cho; Albee Messing
Journal:  Exp Cell Res       Date:  2008-12-29       Impact factor: 3.905

8.  Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.

Authors:  Amy E Steffek; Robert E McCullumsmith; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2008-06-17       Impact factor: 4.939

9.  Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease.

Authors:  Michael R Heaven; Daniel Flint; Shan M Randall; Alexander A Sosunov; Landon Wilson; Stephen Barnes; James E Goldman; David C Muddiman; Michael Brenner
Journal:  J Proteome Res       Date:  2016-06-02       Impact factor: 4.466

10.  Monoclonal antibodies specific for disease-associated point-mutants: lamin A/C R453W and R482W.

Authors:  Marko Roblek; Stefan Schüchner; Veronika Huber; Katrin Ollram; Sylvia Vlcek-Vesely; Roland Foisner; Manfed Wehnert; Egon Ogris
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.